Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Levosimendan

EU orphan designation number: EU/3/18/1980   
Active ingredient: Levosimendan
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Orion Corporation
Orionintie 1, 02200 Espoo, Suomi

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/02/2018 Orphan designation EMA/OD/174/17 (2018)1247 of 22/02/2018